Global private equity and venture capital news and research

Posts Tagged ‘biotechnology’

9 March 2015

Biotech VC funding largely targeting new drugs over improving existing treatments $

bio Venture capital funding of biotechnology businesses is heavily focused towards novel drug R&D rather than improving existing treatments, new research suggests.

14 January 2015

New Leaf, Apposite to exit biotech company Convergence to trade partner

four-leaf-clovers-1381213-m The venture capital backers of UK biotechnology company Convergence Pharmaceuticals have reportedly agreed to sell their stakes to Nasdaq-listed Biogen Idec for $675m.

13 January 2015

Qualcomm Ventures forms $100m investment partnership with Novartis

syringe-974378-m Qualcomm Ventures, the venture capital arm of Qualcomm Incorporated, has partnered with Novartis Pharmaceuticals to target early stage companies in the healthcare tech sector.

9 January 2015

Ally Bridge leads $25m Series B round in Hua Medicine

drug-pharma-medical-healthcare Clinical-stage biotechnology company Hua Medicine has closed a $25m Series B financing led by private equity firm Ally Bridge Group.

18 December 2014

Atlas drives $23m Series A round for biotech company

padlock Atlas Ventures has invested the biggest chunk of cash in a $23m funding round for biotechnology company Padlock Therapeutics.

1 December 2014

Growth hormone deficiency treatment company Ascendis picks up $60m VC-backed Series D

drug tablet pill medical pharma Sofinnova Ventures has joined with OrbiMed and Vivo Capital to lead a $60m Series D financing round for biotech business Ascendis Pharma.

25 November 2014

VC-backed biotech company Promethera pulls in €20m Series C

download (2) Venture capital backed Belgian biotechnology company Promethera Biosciences has raised €20.3m in Series C funding with investors including the Belgian Federal Holding and Investment Company.

24 November 2014

Gimv makes 4.6x return selling stake in biotech company BioMarin

test-tubes-1-1416029-m European investment house Gimv has made an impressive 4.6-times return multiple selling its stake in genetic disorder treatment company business Prosensa to BioMarin

15 October 2014

Biotech sees September private equity, venture capital dealmaking slump $

biotech virus lab Private equity and venture capital dealmaking in the global biotechnology sector suffered a sharp slump in value in September to $180m, new research has shown.

3 October 2014

Forbion holds €92m first close for third healthcare fund

health Netherlands-based private equity firm Forbion Capital Partners has held a €92m first close for its third fund focused on emerging healthcare businesses.

Page 1 of 912345...Last »

Legals & Terms of UsePrivacy Policy

AltAssets is registered as a trademark of Investor Networks Limited (06695690).
Registered Office: Zetland House, 5-25 Scrutton St, London EC2A 4HJ
Content is © AltAssets 2000-2015